We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+10.23%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
AUM
$75.5B
AUM Growth
+$6.03B
Cap. Flow
+$664M
Cap. Flow %
0.88%
Top 10 Hldgs %
13.76%
Holding
1,022
New
110
Increased
407
Reduced
342
Closed
107

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$440M
2
QCOM icon
Qualcomm
QCOM
+$412M
3
BIDU icon
Baidu
BIDU
+$207M
4
UPS icon
United Parcel Service
UPS
+$185M
5
KO icon
Coca-Cola
KO
+$168M

Sector Composition

Rank Sector Weight
1 Energy 16.71%
2 Financials 13.65%
3 Communication Services 11.71%
4 Technology 11.31%
5 Healthcare 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGAM
501
DELISTED
MULTIMEDIA GAMES HOLDING COMPANY INC COM STK (TX)
MGAM
$22.5M 0.03%
652,166
+605,166
+1,288% +$20.7M
GNRC icon
502
Generac Holdings
GNRC
$11.4B
$22.2M 0.03%
521,120
+29,870
+6% +$1.24M
ZG icon
503
Zillow
ZG
$7.42B
$22.2M 0.03%
+788,400
New +$21.8M
TSCO icon
504
Tractor Supply
TSCO
$16.6B
$22.2M 0.03%
1,649,900
-2,200
-0.1% -$27.1K
BZT
505
DELISTED
BEAZER HOMES USA, INC. TANGIBLE EQUITY UNIT
BZT
$22.1M 0.03%
756,000
+731,000
+2,924% +$21M
FANG icon
506
Diamondback Energy
FANG
$56.3B
$22.1M 0.03%
518,620
+194,020
+60% +$7.89M
RH icon
507
RH
RH
$3.41B
$22M 0.03%
347,730
+14,710
+4% +$1.02M
RKT
508
DELISTED
ROCK-TENN COMPANY CL-A
RKT
$21.8M 0.03%
429,740
-41,040
-9% -$2.29M
AEGR
509
DELISTED
Aegerion Pharmaceuticals
AEGR
$21.7M 0.03%
252,860
-98,610
-28% -$8.36M
TFX icon
510
Teleflex
TFX
$5.92B
$21.6M 0.03%
262,997
+27,160
+12% +$2.13M
GBX icon
511
The Greenbrier Companies
GBX
$1.59B
$21.6M 0.03%
872,880
+72,472
+9% +$1.69M
RIGL icon
512
Rigel Pharmaceuticals
RIGL
$705M
$21.5M 0.03%
600,000
OHI icon
513
Omega Healthcare
OHI
$15.3B
$21.4M 0.03%
716,525
-106,290
-13% -$3.23M
BDBD
514
DELISTED
BOULDER BRANDS INC
BDBD
$21.3M 0.03%
1,329,720
+91,180
+7% +$1.39M
TECK icon
515
Teck Resources
TECK
$29B
$21.3M 0.03%
791,800
+10,000
+1% +$251K
JAZZ icon
516
Jazz Pharmaceuticals
JAZZ
$16.1B
$21.2M 0.03%
230,996
-22,180
-9% -$1.79M
CHSP
517
DELISTED
Chesapeake Lodging Trust
CHSP
$21.2M 0.03%
898,727
+116,270
+15% +$2.67M
ABB
518
DELISTED
ABB Ltd
ABB
$21.1M 0.03%
896,119
-131,799
-13% -$2.97M
CSTE icon
519
Caesarstone
CSTE
$72.3M
$21.1M 0.03%
462,700
-30,000
-6% -$1.14M
EXAM
520
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$21.1M 0.03%
+812,750
New +$19M
MCO icon
521
Moody's
MCO
$84.3B
$21.1M 0.03%
300,127
-1,463,482
-83% -$96M
P
522
DELISTED
Pandora Media Inc
P
$20.9M 0.03%
+829,690
New +$17M
FWONA icon
523
Liberty Media Series A
FWONA
$22.6B
$20.8M 0.03%
795,812
+217,154
+38% +$5.45M
AIV
524
Aimco
AIV
$384M
$20.8M 0.03%
5,584,664
-4,949,634
-47% -$19.2M
VALE icon
525
Vale
VALE
$62.4B
$20.8M 0.03%
+1,330,000
New +$19.7M

Similar funds

OppenheimerFunds's Q3 2013 Portfolio in Review

As of Q3 2013, OppenheimerFunds held 1,022 positions worth $75.5B, up 8.7% from $69.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

OppenheimerFunds's Q3 2013 filing shows 110 new, 407 increased, 342 reduced and 107 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 4,300,720 shares worth $144M. The largest sale was Allergan plc, an estimated $440M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Financials and Communication Services.

  • OppenheimerFunds's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class B: 4,300,720 shares worth $144M.
  • OppenheimerFunds added most to Televisa in Q3 2013, an estimated $308M increase.
  • OppenheimerFunds's biggest Q3 2013 reduction was Allergan plc, cutting an estimated $440M.
  • OppenheimerFunds fully exited BROADCOM CORP CL-A in Q3 2013, selling an estimated $164M.
  • OppenheimerFunds's ten largest holdings make up 14% of its $75.5B portfolio in Q3 2013.
  • OppenheimerFunds opened 110 new positions and closed 107 in Q3 2013.
  • OppenheimerFunds's portfolio value rose 8.7% quarter-over-quarter to $75.5B.

Based on OppenheimerFunds's 13F filing for Q3 2013, filed 14 Nov 2013.